COLLPLANT BIOTECH. IS-01 Financial Flexibility Index
COLLPLANT BIOTECH. IS-01 financial flexibility index. COLLPLANT BIOTECH. IS-01 (CPT) has a Financial Flexibility Index of -0.71x as of March 2026. Free cash flow of €-3.04 Million (operating CF €-3.05 Million minus capex €6.00K) represents -1% of total liabilities (€4.30 Million). See COLLPLANT BIOTECH. IS-01 free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of COLLPLANT BIOTECH. IS-01 (2021–2025)
Financial flexibility index of COLLPLANT BIOTECH. IS-01 from 2021 to 2025. Historical Financial Flexibility Index trend for COLLPLANT BIOTECH. IS-01 across 5 annual periods. Check CPT cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
COLLPLANT BIOTECH. IS-01 Financial Flexibility Index by Year (2021–2025)
COLLPLANT BIOTECH. IS-01 financial flexibility index by year from 2021 to 2025. Year-by-year free cash flow to debt coverage for COLLPLANT BIOTECH. IS-01. For the full cash flow conversion analysis, see cash flow conversion of COLLPLANT BIOTECH. IS-01.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -2.00x | €-9.39 Million | €-9.42 Million | €4.70 Million | ▲ +23.1% |
| 2024 | -2.59x | €-13.61 Million | €-14.09 Million | €5.25 Million | ▼ -730.0% |
| 2023 | -0.31x | €-1.81 Million | €-2.76 Million | €5.79 Million | ▲ +86.1% |
| 2022 | -2.26x | €-12.38 Million | €-13.70 Million | €5.49 Million | ▼ -436.7% |
| 2021 | 0.67x | €4.09 Million | €2.50 Million | €6.10 Million | — |